Abstract
Short segments of DNA, which have been synthesized chemically, are commonly known as synthetic oligonucleotides (ODNs). The length of the ODNs typically utilized in the lab varies but is on average between five and forty nucleotides. Chemical modifications may be selectively placed at various locations within the molecule including the backbone, the heterocyclic base, or the sugar moiety (1,2). For the work discussed in this chapter, chemical alterations were placed in three locations: the backbone, the 3’-bridging position between the backbone and the sugar moiety, and at the 5’ end.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Matteucci M. (1996) Structural modifications toward improved antisense oligonucleotides. Perspectives Drug Discovery Design 4, 1–16.
Uhlmann E. and Peyman A. (1990) Antisense oligonucleotides: A new therapeutic principle. Chem. Rev. 90, 544–584.
Eckstein F. (1985) Nucleoside phosphorothioates. Ann. Rev. Biochem. 54, 367–402.
Eckstein F. (1983) Phosphorothioate analogues of nucleotides-tools for the investigation of biochemical processes. Angew. Chem. 6, 423–439.
De Clerq E., Eckstein F., Sternbach H., and Merigan C. (1970) The antiviral activity of thiophosphate-substituted polyribonucleotides in vitro and in vivo. Virology 42, 421–428.
Altmann K. H., Fabbro D., Dean N. M., Geiger T., Monia B. P., Muller M., and Nicklin P. (1996) Second generation antisense oligonucleotides: Structure-activity relationships and the design of improved signal-transduction inhibitors. Biochem. Soc. Trans. 24, 630–637.
Agrawal S., Jiang Z., Zhao Q., Shaw P., Cai Q., Roskey A., Channavajjala L., Saxinger C., and Zhang R. (1997) Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies. Proc. Natl. Acad. Sci. USA 94, 2620–2625.
Heidenreich O., Gryaznov S., and Nerenberg M. (1997) RNase H-independent antisense activity of oligonucleotide N3′ → P5′ phosphoramidates. Nucleic Acids Res. 25, 776–780.
Giles R. V. and Tidd D.M. (1992) Enhanced RNase H activity with methylphosphodiester/phosphodiester chimeric antisense oligonucleotides. Anti-Cancer Drug Design 7, 37–48.
Hermanson G. T. (1996) Tags and probes, in Bioconjugate Techniques, Academic Press San Diego, pp. 297–416.
Murakami A., Nakaura M., Nakatsuji Y., Nagahara S., Tran-Cong Q., and Makino K. (1991) Fluorescent-labeled oligonucleotide probes: detection of hybrid formation in solution by fluorescence polarization spectroscopy. Nucleic Acids Res. 19, 4097–4102.
Landgraf A., Reckmann B., and Pingoud A. (1991) Quantitative analysis of polymerase chain reaction (PCR) products using primers labeled with biotin and a fluorescent dye. Anal. Biochem. 193, 231–235.
Zamecnik P. C. and Stephenson M. L. (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligonucleotide. Proc. Natl. Acad. Sci. USA 75, 280–284.
Bonham M. A., Brown S., Boyd A. L., Brown P. H., Bruckenstein D. A., Hanvey J. C., et al. (1995) An assessment of the antisense properties of RNase H-competent and stericblocking oligomers. Nucleic Acids Res. 23, 1197–1203.
Furdon P. J., Dominski Z., and Kole R. (1989) RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonates, phosphorothioate and phosphodiester bonds. Nucleic Acids Res. 17, 9193–9204.
Brown D. A., Kang S., Gryaznov S. M., DeDionisio L., Heidenreich O., Sullivan S., Xu X., and Nerenberg M. I. (1994) Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269, 26,801–26,805.
Beltinger C., Saragovi H. U., Smith R. M., LeSauteur L., Shah N., DeDionisio L., Christensen L., Raible A., Jarett L., and Gerwitz A. M. (1995) Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95, 1814–1823.
Bannwarth W. (1988) Solid-phase synthesis of oligonucleotides containing phosphoramidate internucleotide linkages and their specific chemical cleavage. Helvetica Chimica Acta 71, 1517–1527.
Gryaznov S. M. and Letsinger R. L. (1992) Synthesis and properties of oligonucleotides containing aminodeoxythymidine units. Nucleic Acids Res. 20, 3403–3409.
Mag M., Schmidt R., and Engels J. W. (1992) Synthesis and selective cleavage of an oligonucleotide containing a bridged non-chiral internucleotide 3′-phosphoramidate linkage. Tetrahedron Lett. 48, 7319–7322.
Gryaznov S. M., Lloyd D. H., Chen J., Schultz R. G., DeDionisio L. A., Ratmeyer L., and Wilson W. D. (1995) Oligonucleotide N3′ → P5′ phosphoramidates. Proc. Natl. Acad. Sci. USA 92, 5798–5802.
DeDionisio L. and Gryaznov S. M. (1995) Analysis of a ribonuclease H digestion of N3′ → P5′ phosphoramidates-RNA duplexes by capillary gel electrophoresis. J. Chromatogr. B 669, 125–131.
Hawley P., Nelson J. S., Fearon K. L., Zon G., and Gibson I. (1999) Comparison of binding of N3′ → P5′ phosphoramidate and phosphorothioate oligonucleotides to cell surface proteins of cultured cells. Antisense Nucleic Acid Drug Dev. 9, 61–69.
Rigl C. T., Lloyd D. H., Tsou D. S., Gryaznov S. G., and Wilson W. D. (1997) Structural RNA mimetics:: N3′ → P5′ phosphoramidate DNA analogs of HIV−1 RRE and TAR helices that bind specifically to rev and tat-related peptides. Biochemistry 36, 650–659.
McCurdy S. N., Nelson J. S., Hirschbein B. L., and Fearon K. L. (1997) An improved method for the synthesis of N3′ → P5′ phosphoramidate oligonucleotides. Tetrahedron Letts. 38, 207–210.
Nelson J. S., Fearon K. L., Nguyen M. Q., McCurdy S. N., Frediani J. E., Foy M. F., and Hirschbein B. L. (1997) N3′ → P5′ oligodeoxyribonucleotide phosphoramidates: a new method of synthesis based on a phosphoramidite amine-exchange reaction. J. Org. Chem 62, 7278–7287.
Fearon K. L., Nelson J. S., Hirschbein B. L., Foy M. F., Nguyen M. Q., Okruszek A., McCurdy S. N., Frediani J. E., DeDionisio L. A., Raible A. M., and Boyd V. (1998) An improved synthesis of oligonucleotide N3′ → P5′ phosphoramidates and their chimera using hindered phosphoramidite monomers and a novel handle for reverse phase purification. Nucleic Acids Res. 26, 3813–3824.
Somers V., Moerkerk P., Murtagh J., and Thunnissen F. (1994) A rapid, reliable method for detection of known point mutations: Point-EXACCT. Nucleic Acids Res. 22, 4840–4841.
DeDionisio L. A. and Lloyd D. H. (1996) Capillary gel electrophoresis and antisense therapeutics: Analysis of DNA analogs. J. Chromatogr. A 735, 191–208.
Cohen A. S., Vilenchik M., Dudley J. L., Gembroys M. W., and Bourque A. J. (1993) High-performance liquid chromatography and capillary gel electrophoresis as applied to antisense DNA. J. Chromatogr. 638, 293–301.
Fearon K. L., Stults J. T., Bergot B. J., Christensen L. M., and Raible A. M. (1995) Investigation of the ‘n-1’ impurity in phosphorothioate oligodeoxynucleotides synthesized by the solid-phase β-cyanoethyl phosphoramidite method using stepwise sulfurization. Nucleic Acids Res. 23, 2754–2761.
Wilk A. and Stec W. J. (1995) Analysis of oligo(deoxynucleoside phosphorothioate)s and their diastereomeric composition. Nucleic Acid Res. 23, 530–534.
Srivatsa G. S., Batt M., Schuette J., Carlson R. H., Fitchett J., Lee C., and Cole P. L. (1994) Quantitative capillary gel electrophoresis assay of phosphorothioate oligonucleotides in pharmaceutical formulations. J. Chromatogr. A 680, 469–477.
DeDionisio L. A., Raible A. M., and Nelson J. S. (1998) Analysis of an oligonucleotide N3′ → P5′ phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis. Electrophoresis 19, 2935–2938.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
DeDionisio, L.A. (2001). Analysis of Modified Oligonucleotides with Capillary Gel Electrophoresis. In: Mitchelson, K.R., Cheng, J. (eds) Capillary Electrophoresis of Nucleic Acids. Methods in Molecular Biology, vol 162. Humana Press. https://doi.org/10.1385/1-59259-055-1:353
Download citation
DOI: https://doi.org/10.1385/1-59259-055-1:353
Publisher Name: Humana Press
Print ISBN: 978-0-89603-779-3
Online ISBN: 978-1-59259-055-1
eBook Packages: Springer Protocols